The side effects of newly discovered COVID strain XEC might not be more severe, but appears to be more contagious, ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

What are the new XEC COVID variant symptoms, and when will it hit the U.S.? Doctors explain what to watch for, and the best ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

By mid-September, the Centers for Disease Control and Prevention reported the Omicron subvariant KP.3.1.1 accounted for most COVID-19 cases. KP.3.1.1 is a member of a group of variants nicknamed ...

In August, the FDA also approved updated mRNA COVID-19 vaccines, which also have a "monovalent (single) component" ...

The XEC variant is currently more common in Europe. Right now, it’s been detected in Poland, Norway, Luxembourg, Ukraine, and Portugal. But XEC has also been spotted in China, and there have been 23 ...

The following is a summary of “A two-variant model of SARS-COV-2 transmission: estimating the characteristics of a newly emerging strain,” published in the September 2024 issue of Infectious Diseases ...

The information contained in this release is as ... 2 strain of the SARS-CoV-2 Omicron JN.1 lineage, submissions pending with other regulatory authorities, expectations regarding the demand ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...

With the U.S. Food and Drug Administration and Centers for Disease Control and Prevention approval of new mRNA COVID-19 ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...